Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Mil Med ; 186(11-12): 1241-1245, 2021 11 02.
Article in English | MEDLINE | ID: mdl-34453163

ABSTRACT

A military soldier sustained a blast injury in Afghanistan, resulting in amputations and hemipelvectomy. He developed New Delhi metallo-beta-lactamase-producing E. coli bacteremia, soft-tissue infection, and sacral osteomyelitis. These organisms are being increasingly discovered in different communities around the world. He was successfully treated with tigecycline and cefiderocol. Cefiderocol is a novel siderophore-based cephalosporine developed to treat serious infections, including those caused by carbapenem-resistant Enterobacterales.


Subject(s)
Blast Injuries , Carbapenems , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Blast Injuries/drug therapy , Carbapenems/pharmacology , Carbapenems/therapeutic use , Cephalosporins , Escherichia coli , Humans , Male , Microbial Sensitivity Tests , Cefiderocol
SELECTION OF CITATIONS
SEARCH DETAIL